The recall notice lists 20 affected products, including mitomycin, naloxone and sodium bicarbonate injections.
“Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening,” the recall notice reads.
The affected products were compounded in Weeki Wachee, Fla., and distributed nationwide.
More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.